Gaining a greater understanding of Singaporeans' understanding of supplements – and the types of services and advice they want pharmacists to provide – has become a key focus for Blackmores Institute as it prepares to host its first symposium in...
Herbalife has reached an agreement in principle to form a joint venture with Traditional Chinese Medicine (TCM) products and services firm Tasly Holding Group.
Shanghai-based nutraceutical and functional foods supplier Acerchem International is to establish a European R&D and manufacturing centre in Swansea, South Wales.
Net profits at supplements manufacturer Blackmores slumped by 42% in the first of half of the financial year, with the firm reporting reduced demand from Chinese ‘daigou’ shoppers who buy in Australia and then ship goods back to their homeland.
One of the world’s biggest makers of nutritional ingredients, Royal DSM, saw pre-tax profits increase by 17% last year, with a strong performance from its nutrition division.
Dairy and nutritional ingredients firm Glanbia has confirmed two strategic acquisitions that will enhance its performance nutrition division by bringing a greater focus on plant-based foods and direct-to-consumer sales.
New Zealand supplement firm Better Health Co, which owns the GO Healthy brand, has sold an 80% stake to an Asian private equity fund to help it tap into international markets.
Nutritional ingredients specialty distributor, Gee Lawson, has merged with Lehvoss UK allowing it to enlarge its international market reach effectively.
Reckitt Benckiser Group plc (RB) has confirmed it is in ‘advanced negotiations’ to acquire all Mead Johnson Nutrition shares for $90 each in cash, valuing Mead Johnson’s entire share capital at approximately $16.7bn.
Curcumin can become as big as omega-3, according to the boss of Indian nutraceutical supplier OmniActive, which has recently received a significant funding boost and made a high-level acquisition.
Infant nutrition company Mead Johnson saw sales in Asia – its largest region – slip 9% year-on-year, 5% on a constant dollar basis, to $1.856bn – although the company recorded ‘strong sales growth’ in its key China market.
